NeoGenomics, Inc.
(NASDAQ : NEO)

( )
NEO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
DVADaVita HealthCare Partners Inc.
-0.76%57.572.4%$100.75m
ACHCAcadia Healthcare Company, Inc.
-0.03%31.1927.3%$100.16m
AMEDAmedisys, Inc.
-0.16%128.9711.7%$65.14m
CHEChemed Corporation
0.09%301.6710.1%$33.63m
MDMEDNAX, Inc.
-2.11%38.5810.6%$30.18m
ADUSAddus HomeCare Corporation
0.19%74.521.2%$26.19m
LHCGLHC Group, Inc.
-0.11%101.402.9%$23.65m
ENSGEnsign Group, Inc.
1.84%46.505.9%$13.99m
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
-2.55%34.740.1%$13.04m
NEONeoGenomics, Inc.
-0.50%13.876.9%$10.48m
USPHU.S. Physical Therapy, Inc.
1.04%112.324.8%$7.95m
RDNTRadNet, Inc.
0.00%12.540.5%$2.70m
PDEXPro-Dex, Inc.
-0.07%13.760.1%$0.87m
COChina Cord Blood Corporation
0.50%6.000.3%$0.52m
AIQAlliance HealthCare Services, Inc.
0.00%13.740.5%$0.24m

Company Profile

NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. The company operates through one segment: Laboratory Testing Segment. The Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.